Jiwei Zhang

5.7k total citations
164 papers, 4.1k citations indexed

About

Jiwei Zhang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jiwei Zhang has authored 164 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Molecular Biology, 34 papers in Pulmonary and Respiratory Medicine and 34 papers in Cancer Research. Recurrent topics in Jiwei Zhang's work include RNA modifications and cancer (22 papers), Cancer-related molecular mechanisms research (22 papers) and Peripheral Artery Disease Management (21 papers). Jiwei Zhang is often cited by papers focused on RNA modifications and cancer (22 papers), Cancer-related molecular mechanisms research (22 papers) and Peripheral Artery Disease Management (21 papers). Jiwei Zhang collaborates with scholars based in China, United States and Italy. Jiwei Zhang's co-authors include Zhaohui Huang, Zehua Bian, Yuan Yin, Bojian Fei, Yuyang Feng, Yaling Hu, Leyuan Zhou, Shengli Li, Xianghuo He and Mingxu Song and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jiwei Zhang

159 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiwei Zhang China 32 2.5k 1.8k 608 561 452 164 4.1k
John S. Bomalaski United States 37 1.8k 0.7× 1.3k 0.7× 429 0.7× 374 0.7× 582 1.3× 132 4.8k
Hongwei Liang China 27 2.9k 1.1× 2.0k 1.1× 246 0.4× 202 0.4× 414 0.9× 74 4.9k
Małgorzata Wygrecka Germany 41 1.6k 0.6× 578 0.3× 1.9k 3.1× 440 0.8× 415 0.9× 127 4.9k
Fan Zhang China 35 2.7k 1.1× 615 0.3× 231 0.4× 178 0.3× 463 1.0× 144 4.3k
Sérgio Paulo Bydlowski Brazil 28 998 0.4× 399 0.2× 420 0.7× 536 1.0× 276 0.6× 145 2.8k
Peter Liu Canada 30 1.7k 0.7× 393 0.2× 534 0.9× 883 1.6× 494 1.1× 76 4.8k
Yuan Yuan China 37 2.9k 1.2× 1.6k 0.9× 934 1.5× 1.6k 2.8× 664 1.5× 348 5.5k
Wenli Liu China 33 1.5k 0.6× 463 0.3× 233 0.4× 297 0.5× 353 0.8× 168 3.2k
Monika Dzieciątkowska United States 39 1.5k 0.6× 284 0.2× 323 0.5× 612 1.1× 183 0.4× 157 4.2k

Countries citing papers authored by Jiwei Zhang

Since Specialization
Citations

This map shows the geographic impact of Jiwei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiwei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiwei Zhang more than expected).

Fields of papers citing papers by Jiwei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiwei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiwei Zhang. The network helps show where Jiwei Zhang may publish in the future.

Co-authorship network of co-authors of Jiwei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Jiwei Zhang. A scholar is included among the top collaborators of Jiwei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiwei Zhang. Jiwei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Jiwei, Han Ju, Oriana Tabarrini, et al.. (2024). Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo. Antiviral Research. 230. 105980–105980. 3 indexed citations
2.
Li, Yuan, et al.. (2024). Immunotherapy in colorectal cancer: Statuses and strategies. Heliyon. 11(1). e41354–e41354. 4 indexed citations
3.
Wang, Mingliang, et al.. (2023). Correlative study on retinal microvascular changes and sex hormones in male patients with central serous chorioretinopathy. SHILAP Revista de lepidopterología. 1 indexed citations
4.
Wang, Hao, Bin Yan, Ming Zhao, Jun Guo, & Jiwei Zhang. (2023). Efficacy of acupuncture in the treatment of psychogenic erectile dysfunction: study protocol for a randomized control trial. SHILAP Revista de lepidopterología. 1 indexed citations
5.
Chen, Mu, et al.. (2023). Cancer and Atrial Fibrillation Comorbidities Among 25 Million Citizens in Shanghai, China: Medical Insurance Database Study. JMIR Public Health and Surveillance. 9. e40149–e40149. 2 indexed citations
6.
Jia, Ruifang, Jiwei Zhang, Fangyuan Shi, et al.. (2023). Discovery of N-substituted oseltamivir derivatives as novel neuraminidase inhibitors with improved drug resistance profiles and favorable drug-like properties. European Journal of Medicinal Chemistry. 252. 115275–115275. 6 indexed citations
7.
Liu, Chuanfeng, Ying Zhang, Ping Li, et al.. (2023). Development of chalcone-like derivatives and their biological and mechanistic investigations as novel influenza nuclear export inhibitors. European Journal of Medicinal Chemistry. 261. 115845–115845. 3 indexed citations
8.
Zhang, Jiwei, et al.. (2022). Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway. Dove Medical Press (Taylor and Francis Group). 17 indexed citations
9.
Zhang, Lina, Fenju Wei, Jiwei Zhang, et al.. (2022). Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors. European Journal of Medicinal Chemistry. 243. 114760–114760. 11 indexed citations
10.
Zhang, Jiwei, Shengli Li, Jianian Zhang, et al.. (2022). Docetaxel resistance-derived LINC01085 contributes to the immunotherapy of hormone-independent prostate cancer by activating the STING/MAVS signaling pathway. Cancer Letters. 545. 215829–215829. 14 indexed citations
11.
12.
Jia, Ruifang, Jian Zhang, Chiara Bertagnin, et al.. (2020). Discovery of highly potent and selective influenza virus neuraminidase inhibitors targeting 150-cavity. European Journal of Medicinal Chemistry. 212. 113097–113097. 21 indexed citations
13.
Bian, Zehua, Jiwei Zhang, Min Li, et al.. (2018). LncRNA–FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling. Clinical Cancer Research. 24(19). 4808–4819. 246 indexed citations
14.
Li, Zhe, Jiwei Zhang, Xinyang Liu, et al.. (2018). The LINC01138 drives malignancies via activating arginine methyltransferase 5 in hepatocellular carcinoma. Nature Communications. 9(1). 1572–1572. 170 indexed citations
15.
Yin, Yuan, Surui Yao, Yaling Hu, et al.. (2017). The Immune-microenvironment Confers Chemoresistance of Colorectal Cancer through Macrophage-Derived IL6. Clinical Cancer Research. 23(23). 7375–7387. 208 indexed citations
16.
Yu, Tao, Yingjun Zhao, Zhixiang Hu, et al.. (2017). MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research. 77(21). 5782–5794. 142 indexed citations
17.
Zhang, Jiwei, Zhe Li, Longzi Liu, et al.. (2017). Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin‐6/STAT3 signaling pathway. Hepatology. 67(1). 171–187. 178 indexed citations
18.
Wang, Peng, Xue Zhang, Fulun Li, et al.. (2017). MiR-130b attenuates vascular inflammation via negatively regulating tumor progression locus 2 (Tpl2) expression. International Immunopharmacology. 51. 9–16. 19 indexed citations
19.
Yin, Yuan, Bin-Bin Zhang, Weili Wang, et al.. (2014). miR-204-5p Inhibits Proliferation and Invasion and Enhances Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating RAB22A. Clinical Cancer Research. 20(23). 6187–6199. 169 indexed citations
20.
Wang, Qifeng, Zhaohui Huang, Weijie Guo, et al.. (2013). MicroRNA-202-3p Inhibits Cell Proliferation by Targeting ADP-Ribosylation Factor-like 5A in Human Colorectal Carcinoma. Clinical Cancer Research. 20(5). 1146–1157. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John S. Bomalaski Breakdown of academic impact, for papers by Hongwei Liang Breakdown of academic impact, for papers by Małgorzata Wygrecka Breakdown of academic impact, for papers by Fan Zhang Breakdown of academic impact, for papers by Sérgio Paulo Bydlowski Breakdown of academic impact, for papers by Peter Liu Breakdown of academic impact, for papers by Yuan Yuan Breakdown of academic impact, for papers by Wenli Liu Breakdown of academic impact, for papers by Monika Dzieciątkowska
Rankless by CCL
2026